Intellia Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$10.68

-0.41 (-3.70%)

As of Aug 8, 1:40 AM ET ·

Analyst Consensus

Buy

Analysts

High

Coverage

Buy 15 56%

Hold 10 37%

Sell 2 7%

Price Target

Analyst Price Target +204.4% upside

Low Target $20.88

Average Target $32.51

High Target $45.64

Current Price $10.68

Current
$10.68

Target
$32.51

$20.88 $32.51 avg $45.64

Scenario Analysis

Bear Case

$20.88

95.5%

Low target

Base Case

$32.51

+204.4%

Avg target

Bull Case

$45.64

+327.3%

High target

Risk/Reward

3.4x

Highly favorable

Price in Context

52-Week High

$28.25

-62.2% from high

52-Week Low

$7.95

+34.3% from low

Target vs 52W High

$32.51

+15.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	44	64%	$91.45	-56.0%